Ibrutinib is not an effective drug in primografts of TCF3-PBX1

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

27 Downloads (Pure)

Research programs

@article{c56b4e3ec88c46f38f4fe3f854115f88,

title = "Ibrutinib is not an effective drug in primografts of TCF3-PBX1",

author = "Cesca Ven and A Boeree and Femke Stalpers and C.M. Zwaan and \{den Boer\}, Monique",

year = "2020",

doi = "10.1016/j.tranon.2020.100817",

language = "English",

volume = "13",

journal = "Translational Oncology",

issn = "1936-5233",

publisher = "Neoplasia Press, Inc.",

number = "10",

}

TY - JOUR

T1 - Ibrutinib is not an effective drug in primografts of TCF3-PBX1

AU - Ven, Cesca

AU - Boeree, A

AU - Stalpers, Femke

AU - Zwaan, C.M.

AU - den Boer, Monique

PY - 2020

Y1 - 2020

U2 - 10.1016/j.tranon.2020.100817

DO - 10.1016/j.tranon.2020.100817

M3 - Article

C2 - 32563910

SN - 1936-5233

VL - 13

JO - Translational Oncology

JF - Translational Oncology

IS - 10

M1 - 100817

ER -